CLDI
CLDI
AMEX · Biotechnology

Calidi Biotherapeutics Inc

$0.67
-0.01 (-1.23%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +7,148.5% upside
Low Target $29.39
Average Target $48.34
High Target $58.89
Current Price $0.67
Current
$0.67
Target
$48.34
$29.39 $48.34 avg $58.89
Scenario Analysis
Bear Case
$29.39
4,307.0%
Low target
Base Case
$48.34
+7,148.5%
Avg target
Bull Case
$58.89
+8,730.4%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$27.04
-97.5% from high
52-Week Low
$0.62
+7.6% from low
Target vs 52W High
$48.34
+78.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%